Table 2. Prevalence of systemic health complaints among exposed population compared with controls.
| Systemic complaints | Control Population | Exposed Population | ||||
| Males (N = 87) | Females (N = 143) | Total (N = 230) | Males (N = 102) | Females (N = 84) | Total (N = 186) | |
| Eyes | 5 (5.7) | 13 (9.1) | 18 (7.8) | 20 (19.6)** | 20 (19.6)** | 34 (18.2)** |
| Teeth and gums | 28 (32.2) | 47 (32.9) | 76 (33) | 42 (41.2) | 42 (41.2) | 78 (41.9) |
| Gastrointestinal | 15 (17.2) | 30 (21) | 44 (19.1) | 40 (39.2)*** | 40 (39.2)*** | 73 (39.3)*** |
| Respiratory | 16 (18.4) | 22 (15.4) | 38 (16.5) | 23 (22.5) | 23 (22.5) | 33 (17.7) |
| Cardiovascular | 15 (17.2) | 24 (16.8) | 39 (16.9) | 13 (12.7) | 13 (12.7) | 24 (12.9) |
| Musculoskeletal | 21 (24.1) | 62 (43.4) | 83 (36.1) | 21 (20.6) | 21 (20.6) | 46 (24.7)* |
| Central Nervous | 8 (9.2) | 29 (20.3) | 37 (16.1) | 16 (15.7) | 16 (15.7) | 35 (18.8) |
| Urinary | 5 (5.7) | 6 (4.2) | 11 (4.8) | 13 (12.7) | 13 (12.7) | 23 (12.4)** |
| Dermal | 8 (9.2) | 7 (4.9) | 15 (6.5) | 25 (24.5)** | 25 (24.5)** | 46 (24.7)*** |
| Eyes | 5 (5.7) | 13 (9.1) | 18 (7.8) | 20 (19.6)** | 20 (19.6)** | 34 (18.2)** |
Numbers in parenthesis denote percentage.
*
p<0.05,
**
p<0.01,
***
p<0.001; significance tested by chi-square test.